Karolinska Institutet

Karolinska Institutet (KI) was established in 1810-1811 for the purpose of training military surgeons in Sweden. KI is the largest medical research center in Stockholm, Sweden and a leading medical university with world-wide respect for their research and technology studies. A KI committee appoints the Nobel Laureates for Physiology or Medicine. KI has numerous Nobel Laureates to their credit over the years. The Department of Cell and Molecular Biology, Pharmacology and RNA research are cutting edge in the field of medical research. The medical school is rated highly for patient care and medical research and education.

Address
SE-171 77 Stockholm, Sweden
Website
http://ki.se/?l=en
Wikipedia
http://en.wikipedia.org/wiki/Karolinska_Institute

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Oncology & Cancer

Prostate cancer blood test equally effective across ethnic groups

The Stockholm3 blood test, developed by researchers at Karolinska Institutet, is equally effective at detecting prostate cancer in different ethnic groups, a new paper published in the Journal of Clinical Oncology reports. ...

Oncology & Cancer

Q&A: New strategy can improve cell therapy against cancer

Researchers at the Center for Infectious Medicine at the Department of Medicine, Huddinge have developed a new strategy that can make cell therapy against cancer work longer in patients. The results are published in the journal ...

Oncology & Cancer

New genetic markers for adrenal cancer may predict survival

A new study from Karolinska Institutet shows that 45 genes may play a crucial role in the prognosis of patients with adrenal cancer. The findings, published in the journal ESMO Open, give hope for a better diagnostic tool ...

Health

Q&A: Researcher discusses a prescription for quitting nicotine

Researcher Tanja Tomson and her colleagues have developed a support tool for health care professionals whose patients want to quit nicotine. Tomson is an associate professor of Public Health who conducts research on tobacco ...

Medications

Popular diabetes drugs may reduce the risk of dementia

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet published in the journal eClinicalMedicine.

page 1 from 40